Research articlePublished 22 May 2020
Effect of Smartphone Application-Enabled Daily Intervention for Patients with Nonalcoholic Steatohepatitis: A Feasibility Study
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background and Aims: The incidences of end-stage liver disease and hepatocellular carcinoma arising from nonalcoholic steatohepatitis (NASH) are rapidly increasing. Although weight reduction is recommended as an initial treatment, no pharmacologic treatments for this condition are presently available. The aims of the current study were(1) to develop a smartphone application-based intervention for weight reduction in NASH patients, and (2) to evaluate the feasibility of using this application in daily clinical practice. Methods: We developed a mobile phone application for NASH patients (NASH App). We then prospectively enrolled 9 clinically diagnosed NASH patients and applied a 24-week intervention using the NASH App in addition to the usual follow-up with laboratory and imaging studies. The use of the NASH App by the patients and the changes in weight and biomarkers were evaluated after the 24-week intervention. Results: The mean patient age was 37.67 years, and 7 patients (77.78%) were male. The mean BMI was 29.63 kg/m2. Seven patients completed the counseling provided by the NASH App. Since one patient was lost to follow-up, the comparison between pre- and post-intervention values was performed for 8 patients. A post-intervention weight reduction was observed in 7 patients, and this weight reduction was statistically significant (p=0.02).Normalization of the ALT level (<30 U/L) was observed in two patients. Conclusion: The NASH App intervention for NASH patients is feasible and acceptable. Further studies using a control arm and a larger population are needed to confirm the efficacy of the NASH App.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Trials
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Masaya Sato”
- BylineArticles whose byline prints “Shin Suzuki”
- BylineArticles whose byline prints “Ryosuke Tateishi”
- BylineArticles whose byline prints “Mizuki Nishibatake Kinoshita”
- BylineArticles whose byline prints “Takuma Nakatsuka”
- BylineArticles whose byline prints “Toshiko Ogawa”
- BylineArticles whose byline prints “Ryo Nakagawa”
- BylineArticles whose byline prints “Kohta Satake”
